New York is currently home to 4773 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
An Osteopathic Assessment of Lower Extremity Somatic Dysfunction in Runners
Recruiting
Runners often experience acute/chronic pain due to pre-existing structural somatic dysfunction and/or acquired various overuse injuries of the lower extremity, specifically affecting the ligaments, tendons, muscles and bones. Common structural and function dysfunctions include but are not limited to patellofemoral pain syndrome (PFPS), Achilles tendonitis, iliotibial band syndrome (ITBS), ligamentous and muscle tears, muscle sprains/strains, stress fractures, pes planus, plantar fasciitis, and s... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/12/2021
Locations: Touro College of Osteopathic Medicine, New York, New York
Conditions: Somatic Dysfunction of Sacral Region, Somatic Dysfunction of Both Sacroiliac Joints, Somatic Dysfunction of Bilateral Lower Extremities
COVID-19 Vaccine Biomarker Study in Multiple Sclerosis
Recruiting
SARS CoV-2 is the virus responsible for the pandemic COVID-19, which has resulted in nearly five million deaths worldwide since its spread in the beginning of 2020. In the United States, there are now two emergency use authorized vaccines that make use of messenger ribonucleic acid (mRNA) based technology that are highly effective for preventing COVID. However, because multiple sclerosis is an autoimmune condition, many individuals with multiple sclerosis take medicines that affect the immune sy... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
11/12/2021
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: Multiple Sclerosis, COVID-19
A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation
Recruiting
This is a Phase 1/2, open-label, multicenter study designed to evaluate the maximum tolerated, safety, tolerability and PK of oral YY-15293 in patients with advanced solid tumors with a KRAS G12C mutation, to confirm the recommended phase 2 dose of YY-15293, and to obtain preliminary efficacy information in patients with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/11/2021
Locations: The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Advanced Solid Tumor
Reducing Daily Stress Among Sexual and Gender Minorities
Recruiting
The purpose of this study is to identify which mindfulness technique, or combination of mindfulness techniques, is most effective at mediating or eliminating stress in emerging adults who are sexual and gender as well as racial or ethnic minorities. Participants will be randomly assigned to one of eight conditions that are composed of the mindfulness techniques of Awareness, Purpose, and Connection.
Gender:
All
Ages:
Between 18 years and 29 years
Trial Updated:
11/10/2021
Locations: New York University School of Global Public Health, New York, New York
Conditions: Social Discrimination, Sexual and Gender Minorities, Mindfulness
The Effect of Joint Hypermobility Syndrome on Delayed Onset of Muscle Soreness and Recovery Time
Recruiting
The purpose of the study is to investigate Joint Hypermobility Syndrome (JHS) and its effect on delayed onset muscle soreness (DOMS) and recovery time. The hypothesis is that people with JHS will experience increased DOMS when compared to non-hypermobile people. The results this study may assist and add to the body of knowledge when treating and exercising patients with JHS, as considerations can possibly be made when treating this population. Subjects with JHS may experience greater DOMS and re... Read More
Gender:
All
Ages:
Between 18 years and 35 years
Trial Updated:
11/01/2021
Locations: New York Institute of Technology, Old Westbury, New York
Conditions: Hypermobility Syndrome
Mobile Application in the Management of Mild to Moderate Postpartum Depression (PPD)
Recruiting
Primary Objective: Evaluate the user experience with the Stella (TM) app for the management of Postpartum Depression in an observed population for 8 calendar weeks.
Gender:
Female
Ages:
Between 18 years and 50 years
Trial Updated:
10/01/2021
Locations: HITLAB, New York, New York
Conditions: Post-partum Depression
Stress Management and Resiliency Training Program for Parkinson's Disease
Recruiting
SMART-PD is an 8-session program designed to decrease the physiological, emotional, cognitive and behavioral effects of stress in participants with Parkinson's disease and their caregivers by teaching cognitive-behavioral techniques and relaxation skills to help participants learn to elicit the relaxation response, alter cognitive appraisals, improve healthy lifestyle behaviors and access social support. The SMART program has been shown to be effective for reducing mental health symptoms such as... Read More
Gender:
All
Ages:
All
Trial Updated:
09/20/2021
Locations: Stony Brook Medical Center, Stony Brook, New York
Conditions: Parkinson Disease
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Recruiting
This is a Phase 1/1b open-label, dose-escalation, and cohort expansion study with BID (tablet) oral dose of MPT-0118 in subjects with advanced or metastatic refractory solid tumors. The study will be conducted in 3 parts: Part A: MPT-0118 dose-escalation Part B: MPT-0118 dose-escalation in combination with pembrolizumab Part C: Cohort expansion of MPT-0118 in combination with pembrolizumab
Gender:
All
Ages:
18 years and above
Trial Updated:
09/15/2021
Locations: Columbia University, New York, New York
Conditions: Solid Tumor, Adult, Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer, Refractory Cancer
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Recruiting
The MyDRUG study is a type of Precision Medicine trial to treat patients with drugs targeted to affect specific genes that are mutated as part of the disease. Mutations in genes can lead to uncontrolled cell growth and cancer. Patients with a greater than 25% mutation to any of the following genes; CDKN2C, FGFR3, KRAS, NRAS, BRAF V600E, IDH2 or T(11;14) can be enrolled to one of the treatment arms. These arms have treatments specifically directed to the mutated genes. Patients that do not have a... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/09/2021
Locations: Mount Sinai School of Medicine, New York, New York
Conditions: Relapsed Refractory Multiple Myeloma
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Recruiting
This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic cell transplant (HCT). Patients diagnosed with B-ALL who are candidates for HCT will be screened by NGS-MRD on a test of bone marrow done before the HCT. Subjects who are pre-HCT NGS-MRD negative will be eligible to receive a non-TBI conditioning regime... Read More
Gender:
All
Ages:
Between 1 year and 25 years
Trial Updated:
08/20/2021
Locations: Roswell Park Cancer Institute, Buffalo, New York
Conditions: B-cell Acute Lymphoblastic Leukemia
Delphi Early Feasibility Study
Recruiting
An early feasibility study to evaluate the safety and first pass effect technical assessment of Delphi Revascularization Device for clot retrieval in Anterior circulation ischemic stroke in the intracranial ICA, MCA M1 and proximal dominant MCA M2, up to 8hrs of symptom onset or Last Known Well (LKW).
Gender:
All
Ages:
18 years and above
Trial Updated:
08/19/2021
Locations: kaledia Health/Buffalo General Medical Center/GVI, Buffalo, New York
Conditions: Ischemic Stroke
tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
Recruiting
Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In a prior Phase-I study, the research team demonstrated feasibility of self-administration of a home-tDCS prototype in 14 patients that applied 15 sessions for each patient at an outpatient center.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
08/13/2021
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Cocaine Use Disorder, Cocaine Dependence